(17314506), R. L., (17314509), E. M., (17314512), A. L., (17314515), N. G., (17314518), I. C., (17314521), A. A., . . . (17314731), D. V. (2025). Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Čikaški stil citiranja (17. izdanje)(17314506), Raphaël Leman, et al. Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. 2025.
MLA način citiranja (9. izdanje)(17314506), Raphaël Leman, et al. Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. 2025.